A plan announced by presidential hopeful Sen. Kamala Harris, D-Calif., would allow HHS to set a "fair price" for any drug available for a lower price in an economically similar country, or when a manufacturer raises a price by more than the rate of inflation. Harris' plan would also impose a 100% tax on all profits manufacturers gain from selling products above the fair price and pass that money onto consumers.
Harris releases plan to target prescription drug prices
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.